Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model

Author:

Sato Kei123ORCID,Misawa Naoko12,Takeuchi Junko S.1,Kobayashi Tomoko1,Izumi Taisuke12,Aso Hirofumi24,Nagaoka Shumpei25,Yamamoto Keisuke26,Kimura Izumi27,Konno Yoriyuki25,Nakano Yusuke12,Koyanagi Yoshio12

Affiliation:

1. Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Kyoto, Japan

2. Laboratory of Systems Virology, Department of Biosystems Science, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan

3. CREST, Japan Science and Technology Agency, Saitama, Japan

4. Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

5. Graduate School of Biostudies, Kyoto University, Kyoto, Japan

6. Graduate School of Medicine, Kyoto University, Kyoto, Japan

7. Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan

Abstract

ABSTRACT Human immunodeficiency virus type 1 (HIV-1), the causative agent of AIDS, originated from simian immunodeficiency virus from chimpanzees (SIVcpz), the precursor of the human virus, approximately 100 years ago. This indicates that HIV-1 has emerged through the cross-species transmission of SIVcpz from chimpanzees to humans. However, it remains unclear how SIVcpz has evolved into pandemic HIV-1 in humans. To address this question, we inoculated three SIVcpz strains (MB897, EK505, and MT145), four pandemic HIV-1 strains (NL4-3, NLCSFV3, JRCSF, and AD8), and two nonpandemic HIV-1 strains (YBF30 and DJO0131). Humanized mice infected with SIVcpz strain MB897, a virus phylogenetically similar to pandemic HIV-1, exhibited a peak viral load comparable to that of mice infected with pandemic HIV-1, while peak viral loads of mice infected with SIVcpz strain EK505 or MT145 as well as nonpandemic HIV-1 strains were significantly lower. These results suggest that SIVcpz strain MB897 is preadapted to humans, unlike the other SIVcpz strains. Moreover, viral RNA sequencing of MB897-infected humanized mice identified a nonsynonymous mutation in env , a G413R substitution in gp120. The infectivity of the gp120 G413R mutant of MB897 was significantly higher than that of parental MB897. Furthermore, we demonstrated that the gp120 G413R mutant of MB897 augments the capacity for viral replication in both in vitro cell cultures and humanized mice. Taken together, this is the first experimental investigation to use an animal model to demonstrate a gain-of-function evolution of SIVcpz into pandemic HIV-1. IMPORTANCE From the mid-20th century, humans have been exposed to the menace of infectious viral diseases, such as severe acute respiratory syndrome coronavirus, Ebola virus, and Zika virus. These outbreaks of emerging/reemerging viruses can be triggered by cross-species viral transmission from wild animals to humans, or zoonoses. HIV-1, the causative agent of AIDS, emerged by the cross-species transmission of SIVcpz, the HIV-1 precursor in chimpanzees, around 100 years ago. However, the process by which SIVcpz evolved to become HIV-1 in humans remains unclear. Here, by using a hematopoietic stem cell-transplanted humanized-mouse model, we experimentally recapitulate the evolutionary process of SIVcpz to become HIV-1. We provide evidence suggesting that a strain of SIVcpz, MB897, preadapted to infect humans over other SIVcpz strains. We further demonstrate a gain-of-function evolution of SIVcpz in infected humanized mice. Our study reveals that pandemic HIV-1 has emerged through at least two steps: preadaptation and subsequent gain-of-function mutations.

Funder

Imai Memorial Trust Foundation

Chube Ito Foundation

Fordays Self-Reliance Support in Japan

Mishima Kaiun Memorial Foundation

TOBE MAKI Scholarship Foundation

Takeda Science Foundation

Ministry of Health, Labour and Welfare

Uehara Memorial Foundation

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Japan Agency for Medical Research and Development

Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care

Sumitomo Foundation

Suzuken Memorial Foundation

Salt Science Research Foundation

Ministry of Education, Culture, Sports, Science and Technology

MEXT | Japan Society for the Promotion of Science

MEXT | Japan Science and Technology Agency

Kanae Foundation for the Promotion of Medical Science

Smoking Research Foundation

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3